TY - CHAP
T1 - Current trends in antimicrobial resistance of escherichia coli
AU - Paitan, Yossi
N1 - Publisher Copyright:
© Springer International Publishing AG, part of Springer Nature 2018.
PY - 2018
Y1 - 2018
N2 - Escherichia coli is the most common Gram-negative bacterial pathogen, presenting both a clinical and an epidemiological challenge. In the last decade, several successful multidrug-resistant high-risk strains, such as strain E. coli ST131 have evolved, mainly due to the growing selective pressure of antimicrobial use. These strains present enhanced fitness and pathogenicity, effective transmission and colonization abilities, global distribution due to efficient dissemination, and resistance to various antimicrobial resistances. Here, we describe the emerging trends and epidemiology of resistant E. coli, including carbapenemase-producing E. coli, E. coli ST131 and colistin resistant E. coli.
AB - Escherichia coli is the most common Gram-negative bacterial pathogen, presenting both a clinical and an epidemiological challenge. In the last decade, several successful multidrug-resistant high-risk strains, such as strain E. coli ST131 have evolved, mainly due to the growing selective pressure of antimicrobial use. These strains present enhanced fitness and pathogenicity, effective transmission and colonization abilities, global distribution due to efficient dissemination, and resistance to various antimicrobial resistances. Here, we describe the emerging trends and epidemiology of resistant E. coli, including carbapenemase-producing E. coli, E. coli ST131 and colistin resistant E. coli.
UR - http://www.scopus.com/inward/record.url?scp=85056030210&partnerID=8YFLogxK
U2 - 10.1007/82_2018_110
DO - 10.1007/82_2018_110
M3 - ???researchoutput.researchoutputtypes.contributiontobookanthology.chapter???
C2 - 30088148
AN - SCOPUS:85056030210
T3 - Current Topics in Microbiology and Immunology
SP - 181
EP - 211
BT - Current Topics in Microbiology and Immunology
PB - Springer Verlag
ER -